Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A synthetic molecule based on a peptide, under investigation for the treatment of glioblastoma by inhibiting angiogenesis.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word cilengitide.

Examples

  • In addition, Merck is developing cilengitide, which is the first in a new class of investigational anti-cancer therapies called integrin inhibitors to reach Phase III of development; it is currently being investigated for the treatment of glioblastoma, SCCHN and NSCLC.

    TradingMarkets 2010

  • In addition, Merck is developing cilengitide, which is the first in a new class of investigational anti-cancer therapies called integrin inhibitors to reach Phase III of development; it is currently being investigated for the treatment of glioblastoma, SCCHN and NSCLC.

    TradingMarkets 2010

  • In addition, Merck is developing cilengitide, which is the first in a new class of investigational anti-cancer therapies called integrin inhibitors to reach Phase III of development; it is currently being investigated for the treatment of glioblastoma,

    The Earth Times Online Newspaper 2010

  • "Our study revealed a previously unknown mechanism through which drugs such as cilengitide behave."

    Health News from Medical News Today 2009

  • Merck KGaA (Merck Serono) companion diagnostics MDxHealth and Merck have extended their existing collaboration using MDxHealth's patented companion diagnostic test (MGMT) with cilengitide, Merck's brain cancer drug that is in phase III clinical testing.

    Reuters: Press Release 2011

  • The researchers also suggested that what they have found could be a previously unknown characteristic of drugs similar to cilengitide.

    Health News from Medical News Today 2009

  • Researchers led by Kairbaan Hodivala-Dilke at Queen Mary, University of London, studied the effects of two integrin inhibitors, one of which, cilengitide, is in phase III clinical trials to treat brain cancer.

    Latest Articles 2009

  • Clinical trials of cilengitide have delivered mixed results so far, and the team says its study points to a possible reason for this.

    Latest Articles 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.